Skip to content
GROWIQCAPITAL

Exchange close

NSE EQ · session of 9 October 2026

₹1,760.00▲ ₹0.20 (+0.01%)
Open
₹1,756.20
Day high
₹1,776.80
Day low
₹1,751.00
Prev close
₹1,759.80
Volume
13,46,107
Turnover
₹237.58Cr
Trades
57,377
Delivery
61.4%

of traded volume

Closing prices

Last 29 sessions held
1,7601,8161,8721,9291,985

Published by the exchange for the session named above. Not a live quote, and not intraday. These are the only figures about this company on the page: GrowIQ does not publish its earnings multiples, ratios, shareholding or screening signals, and does not estimate them.

Market figures are indicative and may be delayed. Past performance does not indicate future returns. Securities and schemes named anywhere on this platform are exemplary, not recommendatory.

NSEPharmaceuticals

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · ISIN INE044A01036

Price is above

The exchange close for this session.

SUNPHARMA at a glance

Sun Pharmaceutical is India's largest pharmaceutical company by revenue, with a specialty franchise in dermatology and ophthalmology alongside its generics business. Sun Pharmaceutical Industries Ltd (NSE EQ: SUNPHARMA) closed at ₹1,760.00 on 9 October 2026, a change of +0.01% on the session. This is the closing price published by the exchange, not a live intraday quote. GrowIQ Capital publishes the exchange's closing prices for this company and does not publish or estimate its earnings multiples, return ratios, debt levels, shareholding or price targets.

What this page does not publish

GrowIQ publishes the exchange’s closing prices for Sun Pharmaceutical Industries Ltd and nothing beyond them. The figures below need company filings that this platform does not yet hold, and they are not estimated, modelled or filled in from a category average. Each one is public — here is where to read it.

  • Company financial statements

    The company's own quarterly results filed with the exchanges, or its annual report

  • Quarterly shareholding pattern filings

    The shareholding pattern published on NSE and BSE each quarter under LODR Regulation 31

  • Corporate action history

    The corporate actions section of the NSE or BSE website

Forecast scenarios

Multi-year Bull, Base and Bear scenarios for SUNPHARMA are shown here only when sourced from a named third-party consensus provider, with the date of that estimate.

GrowIQ Capital does not publish its own price targets. Issuing price targets or research recommendations on listed securities requires registration as a Research Analyst under the SEBI (Research Analysts) Regulations, 2014, which this entity does not hold.

To enable this panel, wire a licensed consensus feed into consensus.source in lib/market-data.ts. Reproducing a provider's estimates also requires the right to redistribute them.

Information only. GrowIQ Capital provides financial data analytics, market information and educational content. We are not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this platform constitutes investment advice or a recommendation to buy or sell any security. Nothing on this page is a recommendation to buy, sell, or hold Sun Pharmaceutical Industries Ltd. Investments in securities markets are subject to market risks. Read all the related documents carefully before investing. Past performance is not indicative of future returns and does not guarantee future results.